A previous retrospective study (first report) on the urinary albumin-creatinine ratio (A/C) was conducted on 107 type 2 diabetes patients over a 9-year-period (1986-1995) based on longitudinally measured data. In the present study we investigated the clinical background of the patients that influenced the in progress with respect to the presence of diabetic retinopathy (DR), comparing it with the clinical background of the patients with diabetic nephropathy (DN).
The subjects were classified into4groups in the first year (1986); an NDR group (N), an SDR group (S), a PPDR group (PP), and a PDR group (P). The results of 9 years of follow-up showed that there were no changes in 59.4% of Group N or 65.0% of Group S, 20.0% of whom improved and were re-classified into Group N. There were no improved patients in Group P. Progression to Group PP or more was seen in 8.7% of Group N and35.0% of Group S, while, 87.5% of Group PP progressed to be Group P.
In the final year of the study (1995), patients were categorized into 3 groups with respect to the changes in DR; Group I (N→N, S→N, S), Group II (N→S), and Group III (progression to Group PP or more). The average HbA
1c level rose significantly (p<0.05) with progression of DR, and the increase was significantly greater than the increase in of DN. None of the cases with good blood glucose control (HbA
1<8.0%)c, showed progression of DR. The prevalence rate of poor blood glucose control (HbA
1c>8.0%) was more significantly correlated with Groups II and III than Group I in the first6of the9years (p<0.05).
Serumlipid values, syotolic and diastolic blood pressure had no significantly relation to progression of DR (whereas they related to it of DN).
These results suggest that hyperglycemia and duration of diabetes were the determinant factors for progression in DR. Hypertension, hyperglycemia, and hyperlipidemia were significantly correlated with progression in DN. The point of no return of DR was the SDR stage.
View full abstract